RE:RE:RE:Financials updateAurora also provided a $50 credit to each new customer at the time of their first order. This will have impacted average sale price per gram. Average price will increase as revenues now coming from repeat customers.
rokkitt wrote: 2nd follow up:
Aurora can afford to have a lower selling price because their cost to produce is lower. Similar to many start-ups in rapidly growing industries, the first aim is to acquire market share. Once a dominant position is established, economies of scale come into play due to sheer size, lowering costs and allowing the behemoths of the industry to turn their gaze toward profitability while slowly increasing prices.
Last point: I doubt very much that the market is saturated. The industry's patient base is rapidly growing and LPs seem to be struggling to keep pace with demand. The bottle neck is supply, not demend.